Intercellular transfer of shed tumor cell gangliosides.
Three distinct steps underlie immumosuppression by tumor gangliosides: (i) their shedding by the tumor cell, (ii) binding to target leukocytes in the tumor microenvironment, and (iii) action upon the target cell. While shedding is well documented, cell to cell transfer of shed gangliosides is not. To address this, we employed a dual chamber culture system. In this system, metabolically radiolabeled lymphoma cells shed gangliosides into the conditioned medium of the contralateral chamber, which contained normal fibroblasts as the target cell. The shed lymphoma cell gangliosides bound avidly to the target fibroblasts in a trypsin-resistant manner (1-2 x 10(6) and 7 x 10(6) molecules/fibroblast in 24 and 48 h). Significantly higher than binding rates of purified lymphoma gangliosides added exogenously, these binding rates in a system which models the in vivo microenvironment suggest that cell to cell ganglioside transfer is a highly efficient process.
Olshefski
R
R
Center for Cancer and Transplantation Biology, Children's National Medical Center, Washington, DC 20010, USA.
Ladisch
S
S
D000818:Animals; D001692:Biological Transport; D018929:Cell Culture Techniques; D002851:Chromatography, High Pressure Liquid; D005347:Fibroblasts / Q000378:metabolism; D005732:Gangliosides / Q000378:metabolism*; D006801:Humans; D008223:Lymphoma / Q000737:chemistry*; D051379:Mice; D014407:Tumor Cells, Cultured
D005732:Gangliosides